News search

    E.g., 09/06/2025
    E.g., 09/06/2025
    Irene Fernández-Nueda, Carlos Cerón y Marta Cortés-Canteli
    About the CNIC
    15 Dec 2020
    CNIC scientists coordinate a European project to develop a biomarker for the early identification of the vascular component in Alzheimer disease

    The BioClotAD project, coordinated by CNIC scientist Dr Marta Cortés Canteli, has been selected by the EU Joint Programme – Neurodegenerative Disease Research (JPND)
    María Ángeles Moro
    About the CNIC
    11 Feb 2020
    "Various diseases and all very mechanistically different, are included under the name of vascular dementia, or better called, cognitive vascular deterioration"

    María Ángeles Moro leads the CNIC's Neurovascular Pathophysiology Laboratory.
    Primera fila: Irene Fernández-Nueda, Marta Cortés-Canteli, Valentín Fuster, Ana Marcos-Díaz y Borja Ibáñez. Detrás: Javier Sánchez-González, Carlos Cerón y Sergio Callejas.
    Research
    9 Oct 2019
    JACC: An oral anticoagulant delays the appearance of Alzheimer disease in mice

    Treatment of mice for 12 months with the anticoagulant drug dabigatran prevented memory loss and preserved cerebral circulation

    Alberto Sanz, Gerente del CNIC; Dr. Jordi Camí, director de la Fundación Pasqual Maragall; Dr. Valentín Fuster, director general del CNIC, y Dr. Borja Ibáñez, Director de Investigación Clínica del CNIC.
    About the CNIC
    30 May 2017
    Two of the of the largest research cohorts in Spain join together to work on the prevention of atherosclerosis and Alzheimer’s

    Los resultados permitirán avanzar en el conocimiento de la interacción entre los diversos factores de riesgo de ambas enfermedades